World Health Organization. Coronavirus (COVID-19) Dashboard. https://covid19.who.int. Accessed 4 Dec 2021
Torjesen I. Covid-19 will become endemic but with decreased potency over time, scientists believe. BMJ. 2021;372: n494.
Article
PubMed
Google Scholar
Hasan T, Beardsley J, Marais BJ, Nguyen TA, Fox GJ. The implementation of mass-vaccination against SARS-CoV-2: a systematic review of existing strategies and guidelines. Vaccines. 2021;9(4):326.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus Pandemic (COVID-19). Our World Data. 2020. https://ourworldindata.org/covid-vaccinations. Assessed 6 Dec 2021.
What are whole virus vaccines and how could they be used against COVID-19. https://www.gavi.org/vaccineswork/what-are-whole-virus-vaccines-and-how-could-they-be-used-against-covid-19. Assessed 5 Dec 2021.
Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical outcomes of A COVID-19 vaccine: implementation over efficacy. Health Affairs (Project Hope). 2021;40(1):42–52.
Article
PubMed
Google Scholar
Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalizations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–29.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: a test-negative case-control study. The BMJ. 2021;373: n1088.
Article
PubMed
PubMed Central
Google Scholar
Chodick G, Tene L, Patalon T, Gazit S, Ben Tov A, Cohen D, et al. Assessment of effectiveness of 1 dose of BNT162b2 vaccine for SARS-CoV-2 infection 13 to 24 days after immunization. JAMA Netw Open. 2021;4(6): e2115985.
Article
PubMed
PubMed Central
Google Scholar
Christie A, Henley SJ, Mattocks L, Fernando R, Lansky A, Ahmad FB, et al. Decreases in COVID-19 cases, emergency department visits, hospital admissions, and deaths among older adults following the introduction of COVID-19 vaccine—United States, September 6, 2020–May 1, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(23):858–64.
Article
CAS
PubMed
PubMed Central
Google Scholar
White EM, Yang X, Blackman C, Feifer RA, Gravenstein S, Mor V. Incident SARS-CoV-2 infection among mRNA-vaccinated and unvaccinated nursing home residents. New Engl J Med. 2021;385(5):474–6.
Article
PubMed
Google Scholar
Graham MS, Sudre CH, May A, Antonelli M, Murray B, Varsavsky T, et al. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B117: an ecological study. Lancet Public Health. 2021;6(5):e335–45.
Article
PubMed
PubMed Central
Google Scholar
Scobie HM, Johnson AG, Suthar AB, Severson R, Alden NB, Balter S, et al. Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status—13 US jurisdictions, April 4–July 17, 2021. MMWR. 2021;70(37):1284–90.
CAS
PubMed
PubMed Central
Google Scholar
Griffin JB, Haddix M, Danza P, Fisher R, Koo TH, Traub E, Gounder P, Jarashow C, Balter S. SARS-CoV-2 infections and hospitalizations among persons aged ≥16 years, by vaccination status—Los Angeles County, California, May 1–July 25, 2021. MMWR. 2021. https://doi.org/10.15585/mmwr.mm7034e5.
Article
PubMed
PubMed Central
Google Scholar
Havers FP, Pham H, Taylor CA, Whitaker M, Patel K, Anglin O, et al. COVID-19-associated hospitalizations among vaccinated and unvaccinated adults ≥18 years—COVID-NET, 13 states, January 1–July 24, 2021. MedRxiv. 2021. https://doi.org/10.1101/2021.08.27.21262356v1.
Article
Google Scholar
Ministry of Health. Coronavirus. Tunis, 2021. http://coronavirus.rns.tn/. Assessed 8 Dec 2021.
Ministry of Health. Vaccination Strategy against covid-19. Tunis, 2021. http://www.santetunisie.rns.tn/images/strategie-vaccination-covid-19.pdf. Assessed 13 Nov 2021.
Ministry of Health. National Dashboard of coronavirus Vaccination. Tunis, 2021. https://evax.tn/vaccinationOD.html. Assessed 13 Nov 2021.
National Institute of Statistics. Statistics of Tunisian population. Tunis, 2021. http://www.ins.tn/statistiques/111. Assessed 12 Oct 2021.
National Observatory of New and Emerging Diseases. Definition of COVID-19 cases in Tunisia. Tunis, 2020. https://www.onmne.tn/?p=10305. Assessed 20 Jan 2022.
Olliaro P, Torreele E, Vaillant M. COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room. Lancet Microbe. 2021;2(7):e279–80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stouten V, Hubin P, Haarhuis F, van Loenhout JAF, Billuart M, Brondeel R, et al. Incidence and risk factors of COVID-19 vaccine breakthrough infections: a prospective cohort study in Belgium. Viruses. 2022;14(4):802.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brunelli SM, Sibbel S, Karpinski S, Marlowe G, Walker AG, Giullian J, et al. Comparative effectiveness of mRNA-based BNT162b2 vaccine versus adenovirus vector-based Ad26COV2S vaccine for the prevention of COVID-19 among dialysis patients. J Am Soc Nephrol. 2022;33(4):688–97.
Article
CAS
PubMed
Google Scholar
Bosch W, Cowart JB, Bhakta S, Carter RE, Wadei HM, Shah SZ, et al. COVID-19 vaccine-breakthrough infections requiring hospitalization in mayo clinic florida through August 2021. Clin Infec Dis. 2021. https://doi.org/10.1093/cid/ciab932.
Article
Google Scholar
Butt AA, Yan P, Shaikh OS, Mayr FB, Omer SB. Rate and risk factors for severe/critical disease among fully vaccinated persons with breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a high-risk national population. Clin Infec Dis. 2021. https://doi.org/10.1093/cid/ciab1023.
Article
Google Scholar
Lipsitch M, Krammer F, Regev-Yochay G, Lustig Y, Balicer RD. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes, and impact. Nat Rev Immunol. 2022;22(1):57–65.
Article
CAS
PubMed
Google Scholar
Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lakbar I, Luque-Paz D, Mege J-L, Einav S, Leone M. COVID-19 gender susceptibility and outcomes: a systematic review. PLoSONE. 2020;15(11): e0241827.
Article
CAS
Google Scholar
Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Agca R, Smulders Y, Nurmohamed M. Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice. Heart. 2022;108(1):73–9.
Article
CAS
PubMed
Google Scholar
Jaén RI, Val-Blasco A, Prieto P, Gil-Fernández M, Smani T, López-Sendón JL, et al. Innate immune receptors, key actors in cardiovascular diseases. JACC Basic Transl Sci. 2020;5(7):735–49.
Article
PubMed
PubMed Central
Google Scholar
Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, et al. Immune response in COVID-19: what is next? Cell Death Differ. 2022;29(6):1107–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kearns P, Siebert S, Willicombe M, Gaskell C, Kirkham A, Pirrie S, et al. Examining the immunological effects of COVID-19 vaccination in patients with conditions potentially leading to diminished immune response capacity—the OCTAVE Trial. Rochester, NY: Social Science Research Network; 2021. Report No.: ID 3910058.
Wang SY, Juthani PV, Borges KA, Shallow MK, Gupta A, Price C, et al. Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B16172) variant era. Lancet Microbe. 2022;3(1):e4-5.
Article
CAS
PubMed
Google Scholar
Tran TNA, Wikle NB, Albert E, Inam H, Strong E, Brinda K, et al. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts. BMC Med. 2021;19:162.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhattacharya A, Ranjan P, Ghosh T, Agarwal H, Seth S, Maher GT, et al. Evaluation of the dose-effect association between the number of doses and duration since the last dose of COVID-19 vaccine, and its efficacy in preventing the disease and reducing disease severity: a single centre, cross-sectional analytical study from India. Diabetes Metab Syndr. 2021;15(5): 102238.
Article
PubMed
PubMed Central
Google Scholar
Alcendor DJ, Matthews-Juarez P, Smoot D, Hildreth JE, Lamar K, et al. Breakthrough COVID-19 infections in the US: implications for prolonging the pandemic. Vaccines. 2022;10(5):755.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, et al. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study. The BMJ. 2021;374: n1943.
Article
PubMed
PubMed Central
Google Scholar
Li L, Han Z-G, Qin P-Z, Liu W-H, Yang Z, Chen Z-Q, et al. Transmission and containment of the SARS-CoV-2 delta variant of concern in Guangzhou, China: a population-based study. PLoS Negl Trop Dis. 2022;16(1): e0010048.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. New Engl J Med. 2021. https://doi.org/10.1056/NEJMoa2108891.
Article
Google Scholar
Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021;27(4):717–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
World Health Organization. The effects of virus variants on COVID-19 vaccines. Geneva, 2021. https://www.who.int/news-room/feature-stories/detail/the-effects-of-virus-variants-on-covid-19-vaccines. Accessed 30 Aug 2022
Chouikha A, Fares W, Laamari A, Haddad-Boubaker S, Belaiba Z, Ghedira K, et al. Molecular epidemiology of SARS-CoV-2 in Tunisia (North Africa) through several successive waves of COVID-19. Viruses. 2022;14(3):624.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, et al. Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines. 2021. https://doi.org/10.1080/14760584.2021.1903879.
Article
PubMed
PubMed Central
Google Scholar
Tartof SY, Slezak JM, Fischer H, Hong V, Ackerson BK, Ranasinghe ON, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet Lond Engl. 2021;398(10309):1407–16.
Article
CAS
Google Scholar
Bates TA, McBride SK, Winders B, Schoen D, Trautmann L, Curlin ME, et al. Antibody response and variant cross-neutralization after SARS-CoV-2 breakthrough infection. JAMA. 2022;327(2):179–81.
Article
CAS
PubMed
Google Scholar